pfizer glp-1 agonist Phase IIb Data Support Monthly Dosing for Obesity Pfizer Acquires a GLP-1 Pipeline

Across studies, fat mass decline predominated, whereas reductions in lean body mass were modest

How GLP-1 and GIP pathways work, why dual-action tirzepatide (Mounjaro) differs from GLP-1-only medicines, and what trial averages mean for UK patients.

The results of the PIONEER-3 trial have now been published in the renowned journal Journal of the American Medical Association (JAMA) and are said to be trend-setting for future therapy of type 2 diabetes.

Check with your health insurance or your employer health program to see if it is covered

Read more about the new GLP-1 pill that outperformed oral semaglutide in a recent Phase III trial.

Heres what that means for health care